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The 97-kDa (LABD97) and 120-kDa (LAD-1) Fragments of
Bullous Pemphigoid Antigen 180/Type XVII Collagen Have
Di¡erent N-Termini
To the Editor:
Bullous pemphigoid antigen 180 (BP180)/type XVII collagen is a
type II-oriented transmembrane protein of hemidesmosomes
(Giudice et al, 1992). Its C-terminal collagenous extracellular por-
tion can be shed from the surface of keratinocytes within the
membrane-proximal 16th noncollagenous A (NC16A) domain
(amino acid (aa) 490^566) resulting in a 120-kDa extracellular
fragment (Hirako et al, 1998). The shedding is mediated by mem-
brane-bound metalloproteases and may be abolished by hydroxa-
mic acid-based metalloprotease inhibitors and tissue inhibitors of
metalloproteases (Franzke et al, 2002; Hirako et al, 2003). These
metalloproteases were recently shown to belong to the group of
ADAMs (a disintegrin and metalloprotease) (Franzke et al, 2002).
Another fragment of the BP180 ectodomain, which reveals a mo-
lecular weight of 97 kDa, can be extracted from epidermis (Zone
et al, 1990). Both the 97- and the 120-kDa fragments of BP180,
also designated as linear IgA bullous disease antigen of 97 kDa
(LABD97) and linear IgA disease antigen 1 (LAD-1), respectively,
represent major antigenic targets of autoantibodies in patients
with linear IgA disease (LAD) (Guide and Marinkovich, 2001).
LAD is a subepidermal blistering disorder characterized by
tissue-bound and circulating IgA autoantibodies to the dermal^
epidermal junction. These IgA autoantibodies preferentially react
with LAD-1 and LABD97, but not with full-length BP180,
suggesting that the cleavage of the ectodomain generates novel
autoantigenic epitopes (Guide and Marinkovich, 2001). The
N-terminus of LABD97 has been identi¢ed at aa position 531
(alanine) within the NC16A domain (Zone et al, 1998). However,
the N-terminus of the 120-kDa fragment has not yet been ¢rmly
established (Franzke et al, 2002).
To address this issue, we immunoa⁄nity puri¢ed LAD-1, shed
from HaCaT cells, which are spontaneously immortalized adult
human keratinocytes, and subjected it to Edman degradation.
Repeated trials found the N-terminus of the protein to be
blocked. To map the cleavage site on the NC16A domain of
BP180, we immunoa⁄nity puri¢ed antibodies against di¡erent
recombinant fragments of the NC16A domain and reacted
the eluted fractions with LAD-1 obtained from HaCaT cells
(Fig 1A,B). Equal amounts of the nine overlapping recombinant
NC16A peptides had been transferred to nitrocellulose (Fig 1B,a).
Rabbit serum SA8010 (Sitaru et al, 2002), generated by immuni-
zation with a stretch of the NC16A region (507^548), reacted
with NC16A fragments 2, 2.5, 3.5, and 4 and weakly with frag-
ments 1.5 and 3 (Fig 1B,b).When SA8010 antibodies were puri-
¢ed against NC16A2, eluted fractions only recognized fragments
1.5 and 2 (Fig 1B,c).When puri¢ed against NC16A2.5, antibodies
reacted with 2.5 and 3 (Fig 1B,d). Antibodies eluted from frag-
ment 2 or 2.5, respectively, were adjusted to the same indirect
immuno£uorescence microscopy titer and were reacted with
concentrated medium of cultured HaCaT cells by immunoblot-
ting. Although antibodies eluted from fragments 2.5 (Fig 1C, lane
3), like original SA8010 serum (Fig 1C, lane 1), strongly reacted
with LAD-1, antibodies eluted from fragment 2 (Fig 1C, lane 4),
like preimmune SA8010 serum (Fig 1C, lane 2), did not label this
protein. Conversely, rabbit SA8010 antibodies eluted from the
LAD-1 band, immobilized on nitrocellulose, reacted with frag-
ment 2.5 but not with fragment 2 (Fig 1D). The observation that
LAD-1 has cross-reacting epitopes with a stretch of aa 521^532
of NC16A2.5 and 3, but not with aa 508^513 (overlapped by
NC16A1.5 and 2), indicated that the N-terminus of LAD-1 loca-
lizes within a stretch corresponding to aa 514^532. It is assumed
that antigenic determinants should include at least four amino
acids (Sela, 1969). Therefore, the two amino acids (aa 531 and
532), shared by both LABD97 and the recombinant NC16A
fragment 2.5, were not likely to account for the presence of cross-
reacting epitopes on LAD-1 and fragment 2.5. These observa-
tions already suggested that LAD-1 and LABD97 have di¡erent
N-termini.
In an attempt to further characterize the N-terminus of the
shed 120-kDa ectodomain, we performed mass spectrometric
analysis on fragments generated by trypsin digestion of LAD-1
immunoa⁄nity-puri¢ed from HaCaT cells. The database search
revealed a peptide (1349.0 Da: APAAGADLDKIGLH) including
N-terminally alanine corresponding to aa position 528 of BP180
sequence (Fig 2A, ¢lled arrowhead). The N-terminus of the identi-
¢ed peptide is not likely to result from trypsin digestion because
this protease cannot cleave the bonding between Met527 and Ala528.
This observation suggests that Ala528 might be the N-terminus of
LAD-1 in HaCaT. Alternatively, the trypsin preparation that we
used might have been contaminated with other proteases. Never-
theless, this observation clearly demonstrated that LAD-1 extends
N-terminally from aa position 531 (Fig 2A, open arrowhead), the
N-terminus of LABD97.
Although mass spectrometric analysis showed that the N-
terminus of the 120-kDa fragment was di¡erent from LABD97,
we could not conclude that Ala528 is the N-terminus of LAD-1. In
another attempt to identify the exact N-terminus of LAD-1, we
performed Edman degradation on protein that was immunoa⁄-
nity-puri¢ed from cultured DJM-1 cells, derived from human
skin squamous cell carcinoma. This analysis revealed leucine at
aa position 524 as the N-terminus of the protein (Fig 2A, arrow)
suggesting the cleavage to occur between Arg523 and Leu524. Align-
ment of amino acid sequences of human, mouse, hamster, canine,
and chicken BP180/type XVII collagen revealed that the region
adjacent to the cleavage site, including Lys521, Asp522, and Leu524,
are conserved between the di¡erent species (Fig 2B, asterisks).
Possibly, these amino acids contribute to formation of the
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recognition site for the protease(s) involved in cleavage of BP180
ectodomain.
The N-terminus of LAD-1 appears to be seven amino acids
upstream/N-terminally from that of LABD97 (Ala531), puri¢ed
from human epidermal extract (Zone et al, 1998). Reasons for
the di¡erent N-termini of the fragments remain obscure. The
97-kDa fragment may be derived from the 120-kDa fragment
by a second degradation at the C-terminal portion (Marinkovich
et al, 1996; Hirako et al, 1998). It is conceivable that the same or
other proteases degrade LAD-1 also at its N-terminus. An alter-
native explanation derives from the hypothesis that cleavage sites
recognized byADAMs are determined by their distance from the
transmembrane domain rather than by a speci¢c recognition site.
Based on this hypothesis, slight di¡erences in the molecular con-
formation of BP180 as found in skin, compared to the protein
produced by keratinocytes in culture, may in£uence the localiza-
tion of the cleavage site within the protein.
In conclusion, we identi¢ed the N-terminus of the 120-kDa
shed ectodomain of BP180 at Leu524, which was found to be dif-
ferent from that of the 97-kDa fragment of this protein. The
N-terminal sequence of the 120-kDa fragment will help to
further dissect the physiologic and pathologic relevance of the
cleavage process.
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